Nukkleus Statistics
Total Valuation
Nukkleus has a market cap or net worth of $4.74 million. The enterprise value is $4.97 million.
| Market Cap | 4.74M |
| Enterprise Value | 4.97M |
Important Dates
The next estimated earnings date is Thursday, August 15, 2024, after market close.
| Earnings Date | Aug 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Nukkleus has 14.80 million shares outstanding. The number of shares has increased by 3.10% in one year.
| Shares Outstanding | 14.80M |
| Shares Change (YoY) | +3.10% |
| Shares Change (QoQ) | +425.95% |
| Owned by Insiders (%) | 55.02% |
| Owned by Institutions (%) | 1.56% |
| Float | 7.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.32
| Current Ratio | 0.32 |
| Quick Ratio | 0.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9,812.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -238.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $1.77M |
| Profits Per Employee | -$1.45M |
| Employee Count | 12 |
| Asset Turnover | 2.91 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.33 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.67 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 26.85 |
| Average Volume (20 Days) | 1,058,219 |
Short Selling Information
The latest short interest is 42,921, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 42,921 |
| Short Previous Month | 168,460 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.58% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, Nukkleus had revenue of $21.30 million and -$17.43 million in losses. Loss per share was -$1.73.
| Revenue | 21.30M |
| Gross Profit | -343,141 |
| Operating Income | -17.46M |
| Pretax Income | -17.43M |
| Net Income | -17.43M |
| EBITDA | -15.05M |
| EBIT | -17.43M |
| Loss Per Share | -$1.73 |
Balance Sheet
The company has $184,111 in cash and $420,619 in debt, giving a net cash position of -$236,508 or -$0.02 per share.
| Cash & Cash Equivalents | 184,111 |
| Total Debt | 420,619 |
| Net Cash | -236,508 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -6.19M |
| Book Value Per Share | -0.42 |
| Working Capital | -6.20M |
Cash Flow
In the last 12 months, operating cash flow was -$1.23 million and capital expenditures -$41,833, giving a free cash flow of -$1.27 million.
| Operating Cash Flow | -1.23M |
| Capital Expenditures | -41,833 |
| Free Cash Flow | -1.27M |
| FCF Per Share | -$0.13 |
Margins
Gross margin is -1.61%, with operating and profit margins of -82.00% and -81.83%.
| Gross Margin | -1.61% |
| Operating Margin | -82.00% |
| Pretax Margin | -81.83% |
| Profit Margin | -81.83% |
| EBITDA Margin | -70.65% |
| EBIT Margin | -81.82% |
| FCF Margin | -5.98% |
Dividends & Yields
Nukkleus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.10% |
| Shareholder Yield | -3.10% |
| Earnings Yield | -367.94% |
| FCF Yield | -26.90% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 26, 2023. It was a forward split with a ratio of 140:100.
| Last Split Date | Dec 26, 2023 |
| Split Type | Forward |
| Split Ratio | 140:100 |
Scores
Nukkleus has an Altman Z-Score of -25.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.99 |
| Piotroski F-Score | 3 |